| ²é¿´: 2731 | »Ø¸´: 8 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
Ï´ÍѼÁ½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÈçºÎÏÂÔØÍâÎÄ»áÒéÎÄÏ×
|
|
| ×î½üÒªÏÂÔØµÄÎÄÏ×ÓÐÁ½ÆªÊÇACS National MeetingµÄÎÄÏ×£¬ÔõôÄÜϵ½È«ÎÄ£¬Ð»Ð»´ó¼Ò°ï棡 |
» ²ÂÄãϲ»¶
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ16È˻ظ´
ϵͳ²é²»µ½
ÒѾÓÐ10È˻ظ´
»ù½ð²»ÖУ¬¹²Ãã
ÒѾÓÐ3È˻ظ´
Ôõô²é°¡
ÒѾÓÐ5È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ10È˻ظ´
ÎÒ²»Àí½â£¡
ÒѾÓÐ13È˻ظ´
2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½
ÒѾÓÐ9È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ25È˻ظ´
2026Äê8ÔÂ25ÈÕ¹ú×ÔÈ»·Å°ñǰͻȻÊÕµ½ÁÐÈëÆÀÉóר¼ÒÓʼþ£¬ÓйØÏµÂð£¿
ÒѾÓÐ28È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ26È˻ظ´
Ï´ÍѼÁ
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 932.5
- É¢½ð: 38
- Ìû×Ó: 87
- ÔÚÏß: 32.4Сʱ
- ³æºÅ: 969057
- ×¢²á: 2010-03-12
- ÐÔ±ð: MM
- רҵ: ÌìȻҩÎﻯѧ
3Â¥2011-05-04 20:15:52
cfm877
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 5903.8
- É¢½ð: 3751
- ºì»¨: 26
- ɳ·¢: 357
- Ìû×Ó: 6677
- ÔÚÏß: 976.9Сʱ
- ³æºÅ: 466781
- ×¢²á: 2007-11-24
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ

4Â¥2011-05-04 20:17:27
Ï´ÍѼÁ
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 932.5
- É¢½ð: 38
- Ìû×Ó: 87
- ÔÚÏß: 32.4Сʱ
- ³æºÅ: 969057
- ×¢²á: 2010-03-12
- ÐÔ±ð: MM
- רҵ: ÌìȻҩÎﻯѧ
5Â¥2011-05-04 20:22:01
cfm877
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 5903.8
- É¢½ð: 3751
- ºì»¨: 26
- ɳ·¢: 357
- Ìû×Ó: 6677
- ÔÚÏß: 976.9Сʱ
- ³æºÅ: 466781
- ×¢²á: 2007-11-24
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ
Ï´ÍѼÁ(½ð±Ò+1): ÕªÒªÎÒϵ½ÁË£¬Ã»ÓÐÈ«Îİ¡£¡²»¹ÜÔõÑù£¬Ð»Ð»£¡ 2011-05-05 18:00:48
|
ʵÔڸ㲻¶¨£¬Ö»²éµ½ÁËÕªÒª Synthesis, SAR and biological evaluation of racemic abyssinone II and analogs as potential aromatase inhibitors for prevention of breast cancer. Maiti, Arup; Cuendet, Muriel; Croy, Vicki L.; Endringer, Denise C.; Pezzuto, John M.; Cushman, Mark. Department of Medicinal Chemistry and Molecular Pharmacology and The Purdue Cancer Center, Purdue University, West Lafayette, IN, USA. Abstracts of Papers, 233rd ACS National Meeting, Chicago, IL, United States, March 25-29, 2007 (2007), MEDI-093. Publisher: American Chemical Society, Washington, D. C CODEN: 69JAUY Conference; Meeting Abstract; Computer Optical Disk written in English. AN 2007:295526 CAPLUS Abstract Aromatase, which converts androgens to estrogens and catalyzes the transformation of pro-carcinogens to carcinogenic metabolites, is an attractive target for the chemoprevention of breast cancer. Inhibitors of aromatase show an overall superior efficacy over selective estrogen receptor modulators (SERMs), a std. therapy used in the treatment of estrogen-receptor-pos. breast cancer in postmenopausal women. Previous studies showed that (S)-abyssinone, isolated from Broussonetia papyrifera L., is a potent aromatase inhibitor. An efficient approach to the synthesis of racemic abyssinone II and a series of its analogs as well as their biol. evaluation as potential selective aromatase inhibitors are described. Racemic abyssinone II showed an IC50 value of 28.0 .mu.M by fluorimetric assay. Several novel racemic analogs displayed increased aromatase inhibitory activity relative to abyssinone II, with IC50 values starting from as low as 1.9 .mu.M. A structure-activity (SAR) model was established to search for new potent chemopreventive agents. This research was supported by program project grant P01 CA48112 funded by the NCI. |

6Â¥2011-05-04 20:35:41









»Ø¸´´ËÂ¥
ͶƱ: